Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HSPB1 facilitates chemoresistance through inhibiting ferroptotic cancer cell death and regulating NF-κB signaling pathway in breast cancer
Yiran Liang, Yajie Wang, Yan Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Versatile function of NF-ĸB in inflammation and cancer
Qiang Ma, Shuai Hao, Weilong Hong, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 24
crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer
Yutian Zou, Anli Yang, Bo Chen, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101126-101126
Closed Access | Times Cited: 23
Ferroptosis inhibitors: past, present and future
Lei Zhang, Yi Luo, Yang Xiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 17
Ferroptosis: the emerging player in remodeling triple-negative breast cancer
Jie Li, Dejiao He, Sicheng Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 29
Nano-drug delivery system for the treatment of multidrug-resistant breast cancer: Current status and future perspectives
Lanwen Gao, Fansu Meng, Zhenjiang Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117327-117327
Open Access | Times Cited: 9
Molecular Insights on Signaling Cascades in Breast Cancer: A Comprehensive Review
Venketesh K. Panda, Barnalee Mishra, Samikshya Mahapatra, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 234-234
Open Access | Times Cited: 1
SH3GL1‐activated FTH1 inhibits ferroptosis and confers doxorubicin resistance in diffuse large B‐cell lymphoma
Zi‐Wen Duan, Wei‐Ting Wang, Yan Wang, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 3
Open Access | Times Cited: 1
Ferroptosis as a promising targeted therapy for triple negative breast cancer
Kasra Mokhtarpour, Sepideh Razi, Nima Rezaei
Breast Cancer Research and Treatment (2024) Vol. 207, Iss. 3, pp. 497-513
Closed Access | Times Cited: 8
A New Perspective in the Treatment of Ischemic Stroke: Ferroptosis
Lei Zhang, Xin Yue Bai, Ke Yao Sun, et al.
Neurochemical Research (2024) Vol. 49, Iss. 4, pp. 815-833
Closed Access | Times Cited: 6
Boosting ferroptosis by intervention of redox balance and synergetic with photothermal/photodynamic therapy for suppression of pancreatic cancer
Yixun Jin, Jia Huang, Yuming Tang, et al.
Chemical Engineering Journal (2024) Vol. 497, pp. 154569-154569
Closed Access | Times Cited: 4
Integration of machine learning and experimental validation to identify the prognostic signature related to diverse programmed cell deaths in breast cancer
Longpeng Li, Jinfeng Zhao, Yaxin Wang, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Ferroptosis Transcriptional Regulation and Prognostic Impact in Medulloblastoma Subtypes Revealed by RNA-Seq
Christophe Desterke, Yuanji Fu, Jenny Bonifacio-Mundaca, et al.
Antioxidants (2025) Vol. 14, Iss. 1, pp. 96-96
Open Access
HSP27/IL-6 axis promotes OSCC chemoresistance, invasion and migration by orchestrating macrophages via a positive feedback loop
Ying Qi, Juan Cao, Mingjing Jiang, et al.
Cell Biology and Toxicology (2025) Vol. 41, Iss. 1
Open Access
More than Just Protein Folding: The Epichaperome, Mastermind of the Cancer Cell
Haneef Ahmed Amissah, Maxwell Hubert Antwi, Tawfeek Ahmed Amissah, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 204-204
Open Access
Targeting the S100A9/P38 MAPK/HSPB1 axis as a novel approach for aortic dissection therapy
Likang Ma, Linfeng Xie, Qingsong Wu, et al.
International Immunopharmacology (2025) Vol. 149, pp. 114225-114225
Closed Access
Knockdown of EBP1 promotes doxorubicin-induced apoptosis in renal clear cell carcinoma cells through activation of the p38/HIF-1α pathway
Lina Ma, Jiaqi Huo, Shuxia Cao, et al.
Oncology Letters (2025) Vol. 29, Iss. 4
Open Access
Cancer-associated fibroblasts promote doxorubicin resistance in triple-negative breast cancer through enhancing ZFP64 histone lactylation to regulate ferroptosis
Kejing Zhang, Lei Guo, Xin Li, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Gravitational Forces and Matrix Stiffness Modulate the Invasiveness of Breast Cancer Cells in Bioprinted Spheroids
Louise Breideband, Kaja Nicole Wächtershäuser, Ryan Sarkar, et al.
Materials Today Bio (2025) Vol. 31, pp. 101640-101640
Open Access
Nanomaterials targeting iron homeostasis: a promising strategy for cancer treatment
Bin Li, Dan Mu, Ziyue Cheng, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
Reducing toxicity and enhancing efficacy of doxorubicin by liposomal doxorubicin and aprepitant in breast cancer
Atefeh Ghahremanloo, Bahareh Erfani, Fereshteh Asgharzadeh, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
HSPB1 suppresses oxLDL-induced vascular smooth muscle cell ferroptosis by inhibiting DPP4
Yi Li, Lijun Zhang, Qi Zhang, et al.
Archives of Biochemistry and Biophysics (2025), pp. 110400-110400
Closed Access
Targeting Cancer With Bifunctional Peptides: Mechanism of Cell Entry and Inciting Cell Death
Maria F. Setiawan, Oliver Rudan, Ingo Schmidt‐Wolf
Cancer Science (2025)
Open Access
Mechanisms Associated with Mitophagy and Ferroptosis in Cerebral Ischemia-reperfusion Injury
Yuping Ma, X Wang, Yahui Li, et al.
Journal of Integrative Neuroscience (2025) Vol. 24, Iss. 3
Open Access
Vildagliptin attenuates doxorubicin-induced hepatotoxicity via activating Nrf2/HO-1 and SIRT1 and suppressing NF-κB signals in rats
Heba M. Mahmoud, Emad H.M. Hassanein, Marwa M. Khalaf
Immunopharmacology and Immunotoxicology (2025), pp. 1-11
Closed Access
COPS5 Triggers Ferroptosis Defense by Stabilizing MK2 in Hepatocellular Carcinoma
Aiyun Luo, Wenxin Zheng, Qiong Zhang, et al.
Advanced Science (2025)
Open Access
Page 1 - Next Page

Scroll to top